Dorsaf Hedhli

Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant.

I. Dimier-Poisson, M. Mévélec, J. W. Judge, 2009, Vaccine.

Mycobacterium tuberculosis Lacking All Mycolic Acid Cyclopropanation Is Viable but Highly Attenuated and Hyperinflammatory in Mice

M. Glickman, K. Huygen, D. Barkan, 2012, Infection and Immunity.

Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection.

M. Lebrun, I. Dimier-Poisson, M. Mévélec, 2009, Vaccine.

Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis.

N. Moiré, I. Dimier-Poisson, J. Pierre, 2011, Vaccine.

The antigen-specific response to Toxoplasma gondii profilin, a TLR11/12 ligand, depends on its intrinsic adjuvant properties

N. Moiré, F. Laurent, I. Dimier-Poisson, 2016, Medical Microbiology and Immunology.

M.tuberculosis Mutants Lacking Oxygenated Mycolates Show Increased Immunogenicity and Protective Efficacy as Compared to M. bovis BCG Vaccine in an Experimental Mouse Model

M. Glickman, M. Daffé, K. Huygen, 2013, PloS one.

The antigen-specific response to Toxoplasma gondii profilin, a TLR11/12 ligand, depends on its intrinsic adjuvant properties

N. Moiré, F. Laurent, I. Dimier-Poisson, 2016, Medical Microbiology and Immunology.